<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(5)</volume><submitter>Wegrzyniak O</submitter><funding>European Foundation for the Study of Diabetes</funding><funding>Barndiabetesfondens</funding><funding>Magnus Bergvall Foundation</funding><funding>Swedish Research Council</funding><pubmed_abstract>Non-invasive assessment of fibrogenic activity, rather than fibrotic scars, could significantly improve the management of fibrotic diseases and the development of anti-fibrotic drugs. This study explores the potential of an Affibody molecule (Z09591) labeled with the Al(18)F-restrained complexing agent (RESCA) method as a tracer for the non-invasive detection of fibrogenic cells. Z09591 was functionalized with the RESCA chelator for direct labeling with [&lt;sup>18&lt;/sup>F]AlF. &lt;i>In vivo&lt;/i> positron emission tomography/magnetic resonance imaging scans on U-87 tumor-bearing mice exhibited high selectivity of the resulting radiotracer, [&lt;sup>18&lt;/sup>F]AlF-RESCA-Z09591, for platelet-derived growth factor receptor β (PDGFRβ), with minimal non-specific background uptake. Evaluation in a mouse mod</pubmed_abstract><journal>iScience</journal><pagination>109688</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11039342</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Non-invasive PET imaging of liver fibrogenesis using a RESCA-conjugated Affibody molecule.</pubmed_title><pmcid>PMC11039342</pmcid><pubmed_authors>Persson J</pubmed_authors><pubmed_authors>Mitran B</pubmed_authors><pubmed_authors>Wegrzyniak O</pubmed_authors><pubmed_authors>Lechi F</pubmed_authors><pubmed_authors>Cheung P</pubmed_authors><pubmed_authors>Nordstrom H</pubmed_authors><pubmed_authors>Korsgren O</pubmed_authors><pubmed_authors>Frejd FY</pubmed_authors><pubmed_authors>Eriksson J</pubmed_authors><pubmed_authors>Lofblom J</pubmed_authors><pubmed_authors>Bitzios A</pubmed_authors><pubmed_authors>Eriksson O</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Non-invasive PET imaging of liver fibrogenesis using a RESCA-conjugated Affibody molecule.</name><description>Non-invasive assessment of fibrogenic activity, rather than fibrotic scars, could significantly improve the management of fibrotic diseases and the development of anti-fibrotic drugs. This study explores the potential of an Affibody molecule (Z09591) labeled with the Al(18)F-restrained complexing agent (RESCA) method as a tracer for the non-invasive detection of fibrogenic cells. Z09591 was functionalized with the RESCA chelator for direct labeling with [&lt;sup>18&lt;/sup>F]AlF. &lt;i>In vivo&lt;/i> positron emission tomography/magnetic resonance imaging scans on U-87 tumor-bearing mice exhibited high selectivity of the resulting radiotracer, [&lt;sup>18&lt;/sup>F]AlF-RESCA-Z09591, for platelet-derived growth factor receptor β (PDGFRβ), with minimal non-specific background uptake. Evaluation in a mouse mod</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-06-02T01:43:44.811Z</modification><creation>2025-04-06T03:15:49.022Z</creation></dates><accession>S-EPMC11039342</accession><cross_references><pubmed>38660405</pubmed><doi>10.1016/j.isci.2024.109688</doi></cross_references></HashMap>